Evidence map›Paper›PMID 41419467›Full record

ArticleNature communications2025

Author Correction: Inactivation of cytidine triphosphate synthase 1 prevents fatal auto-immunity in mice.

Claire Soudais, Romane Schaus, Camille Bachelet, Norbert Minet, Sara Mouasni, Cécile Garcin, Caique Lopes Souza, Pierre David, Clara Cousu, Hélène Asnagli and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Claire SoudaisLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France. claire.soudais@inserm.fr.ORCID http://orcid.org/0000-0002-4387-6649
Romane SchausLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France.
Camille BacheletLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France.ORCID http://orcid.org/0000-0003-3800-3816
Norbert MinetLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France.ORCID http://orcid.org/0000-0003-3570-4166
Sara MouasniLaboratory of Molecular Basis of Altered Immune Homeostasis Inserm UMR 1163, Institut Imagine, Paris, France.
Cécile GarcinLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France.
Caique Lopes SouzaLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France.
Pierre DavidTransgenesis Platform, Laboratoire d'Expérimentation Animale et Transgenèse (LEAT), Institut Imagine-Structure Fédérative de Recherche Necker INSERM US24/CNRS, Paris, France.ORCID http://orcid.org/0009-0006-1611-5648
Clara CousuUniversité Paris Cité, CNRS UMR 8253, INSERM U1151, Institut Necker Enfants Malades, Paris, France.
Hélène AsnagliStep-Pharma, Technoparc du Pays-de-Gex, Saint-Genis-Pouilly, France.
Andrew ParkerStep-Pharma, Technoparc du Pays-de-Gex, Saint-Genis-Pouilly, France.
Paul Palmquist-GomesUniversité de Paris Cité, Paris, France.
Fernando E SepulvedaLaboratory of Molecular Basis of Altered Immune Homeostasis Inserm UMR 1163, Institut Imagine, Paris, France.ORCID http://orcid.org/0000-0001-5865-4929
Sébastien StorckUniversité Paris Cité, CNRS UMR 8253, INSERM U1151, Institut Necker Enfants Malades, Paris, France.ORCID http://orcid.org/0000-0002-2682-5962
Sigolène M MeilhacUniversité de Paris Cité, Paris, France.
Alain Fischer *Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France.
Emmanuel Martin *Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France.ORCID http://orcid.org/0000-0003-4211-7373
Sylvain LatourLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France. sylvain.latour@inserm.fr.ORCID http://orcid.org/0000-0001-8238-4391

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41419467
PMCPMC12717045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.